These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 18367854

  • 1. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 2. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 4. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Dec; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J, Torok N.
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Mar; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006 Mar; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 8. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 9. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C.
    J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
    [Abstract] [Full Text] [Related]

  • 10. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1115-8. PubMed ID: 12677985
    [Abstract] [Full Text] [Related]

  • 11. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B, Stremmel W.
    Z Gastroenterol; 2003 Jan 10; 41(1):77-90. PubMed ID: 12541180
    [Abstract] [Full Text] [Related]

  • 12. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun 10; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 13. [Non-alcoholic steatohepatitis].
    Duvnjak M, Virović L.
    Acta Med Croatica; 2003 Jun 10; 57(3):189-99. PubMed ID: 14582465
    [Abstract] [Full Text] [Related]

  • 14. The treatment of NAFLD.
    Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, Capasso R, Coppola F, Dauria M, Loguercio C.
    Eur Rev Med Pharmacol Sci; 2005 Jun 10; 9(5):299-304. PubMed ID: 16231594
    [Abstract] [Full Text] [Related]

  • 15. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H, Kaser A.
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar 10; 2(3):148-55. PubMed ID: 16265156
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N, Borlak J.
    Pharmacol Rev; 2008 Sep 10; 60(3):311-57. PubMed ID: 18922966
    [Abstract] [Full Text] [Related]

  • 17. Nonalcoholic steatohepatitis.
    Diehl AM.
    Semin Liver Dis; 1999 Sep 10; 19(2):221-9. PubMed ID: 10422202
    [Abstract] [Full Text] [Related]

  • 18. Hepatic microcirculation in fatty liver disease.
    Farrell GC, Teoh NC, McCuskey RS.
    Anat Rec (Hoboken); 2008 Jun 10; 291(6):684-92. PubMed ID: 18484615
    [Abstract] [Full Text] [Related]

  • 19. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
    Park SH.
    Korean J Hepatol; 2009 Dec 10; 15 Suppl 6():S34-9. PubMed ID: 20037278
    [Abstract] [Full Text] [Related]

  • 20. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W, McCullough AJ.
    Semin Gastrointest Dis; 2002 Jan 10; 13(1):17-30. PubMed ID: 11944630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.